How Regaining Full Rights to Rett Syndrome Gene Therapy Has Changed Taysha (TSHA)’s Investment Story

Recently, Taysha Gene Therapies announced it has regained full rights to its lead gene therapy candidate TSHA-102 for…
#NewsBeep #News #Headlines #BreakthroughTherapy #clinicalsignificance #genetherapies #Latvia #LV #regulatoryapproval #regulatorysignificance #Rettsyndrome
https://www.newsbeep.com/193054/